197 molecular-modeling-or-molecular-dynamic-simulation positions at University of Virginia
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
mechanism of action of drugs and/or biologics in in vitro models of cancer. Candidates with expertise using more sophisticated molecular techniques like CRISPR, gene expression studies, confocal microscopy
-
and titrating virus stocks Routine tissue culture General molecular biology techniques (nucleic acid isolation, RT-PCR, RNAseq), microscopy, and animal work The lab specialist will also have tasks
-
the role of tumor microenvironment in cancer development. We dissect the cellular and molecular mechanisms of carcinogenesis from a developmental perspective using Neurofibromatosis Type 1 (NF1), a common
-
cardiovascular treatments. In this role you will apply both machine learning predictive modelling and human genetic analyses of non-coding regulatory sequences to identify cell-specific targets for coronary artery
-
normal and cancer cells, and mouse models. Research in the Trinh lab centers on protein- and RNA- mediated gene regulation via modulating chromatin architecture in development of immune cells, particularly
-
this position will have some latitude to pursue ideas and novel directions, in consultation with the PI. Responsibilities will include the preparation, isolation and characterization of new molecular inorganic
-
will be focusing on: 1.) Defining molecular changes that occur within reactive astrocytes in Down Syndrome and Alzheimer’s Disease, 2.) Targeting astrocytes to improve neuronal synaptic dysfunction, 3
-
disease research, neurobiology, or immunology Experience with mouse models of neurodegenerative disease Experience with one or more of the following methods: confocal microscopy, cell or tissue culture
-
technology, immunology, and general molecular biology techniques, including the use of using animal models. Responsibilities include working with small animals, laboratory procedures, assisting with collection
-
molecular mechanisms of carcinogenesis from a developmental perspective using Neurofibromatosis Type 1 (NF1), a common tumor predisposition human genetic disorder, as a model. While working on